🇺🇸 FDA
Drug

carisoprodol

Brand: CARISOPRODOL

approved

Quick answer

carisoprodol (CARISOPRODOL), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

Key facts

INN
carisoprodol
Brand
CARISOPRODOL
Route
ORAL
Formulation
CAPSULE
Originator
TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12427155

Treatment for tau-related diseases

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12419873

Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related di

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12414999

Compositions and methods relating to macrophages and/or monocytes with adhered p

Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12396974

Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12364708

Injectable scaffold for treatment of intracranial aneurysms and related technolo

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12359223

Systems and methods for modulating chromosomal rearrangements

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350258

Compositions and methods for treatment of skin-related diseases and promoting de

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350298

Microbiome related immunotherapies

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is carisoprodol?

carisoprodol (CARISOPRODOL), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for carisoprodol?

CARISOPRODOL is a marketed brand name for carisoprodol. Check FDA Drugs@FDA for the current US label holder.